[Secondary hyperaldosteronisms].
D000450:Aldosterone / Q000097:blood / Q000652:urine; D000804:Angiotensin II / Q000378:metabolism*; D006333:Heart Failure / Q000150:complications; D006929:Hyperaldosteronism / Q000209:etiology / Q000378:metabolism*; D006947:Hyperkalemia / Q000150:complications; D006974:Hypertension, Malignant / Q000150:complications; D006977:Hypertension, Renal / Q000150:complications; D007008:Hypokalemia / Q000150:complications; D007676:Kidney Failure, Chronic / Q000150:complications; D008103:Liver Cirrhosis / Q000150:complications; D009638:Norepinephrine / Q000378:metabolism*; D010673:Pheochromocytoma / Q000150:complications; D011188:Potassium / Q000096:biosynthesis*; D012083:Renin / Q000378:metabolism; D013268:Stimulation, Chemical
D000804:Angiotensin II; D000450:Aldosterone; D012083:Renin; D011188:Potassium; D009638:Norepinephrine
Les hyperaldostéronismes secondaires.